Atlas Trials

Kaposiform Hemangioendothelioma

8 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Kaposiform Hemangioendothelioma

RecordFirmDate
Percutaneous Administration of Sirolimus in the Treatment of Superficial Complicated Vascular Anomalies (NCT04921722)Children's Hospital of Fudan University2021-10-22
The Effect of Sirolimus on Immunizations During the Treatment of Kaposiform Hemangioendothelioma (NCT05351216)Children's Hospital of Fudan University2021-03-01
Efficacy and Safety of Different Concentrations of Sirolimus in the Treatment of Kaposiform Hemangioendothelioma. (NCT04775173)West China Hospital2021-02-17
Guided Discontinuation Versus Maintenance Treatment of Sirolimus in Pediatric Patients With Kaposiform Hemangioendothelioma (NCT04448873)Children's Hospital of Fudan University2020-07-01
Safety and Efficacy of Low-dose Sirolimus to Kaposiform Hemangioendothelioma (NCT04077515)Children's Hospital of Fudan University2019-05-01
Sirolimus Versus Sirolimus Plus Prednisolone for Kaposiform Hemangioendothelioma (NCT03188068)West China Hospital2017-06-01
Identification of Biomarkers for Patients with Vascular Anomalies (NCT03001180)Children's Hospital Medical Center, Cincinnati2015-04-01

Track Kaposiform Hemangioendothelioma automatically

Every clearance here is in the API, with alerts when new ones post.